- Dr. Elisa Magrin a présenté un poster sur les travaux suivants :
Improving lentiviral transduction efficiency of cd34+ hematopoietic stem cells using poloxamers or lentiblast premium®: optimization toward a gene therapy procedure for sickle cell disease
- Dr. Ugo Chartral a présenté les travaux suivants :
Expanding access to haploidentical transplantation: Clinical feasibility of a centralized nationwide distribution model for fresh TCRa/b-depleted grafts in France. GMP-manufactured allogenic human T lymphoid progenitors (HTLP) promote early and sustained T-cell recovery after CD34+-selected haploidentical HSCT in SCID patients: Final results of the HTLP-SCID study Improving lentiviral transduction efficiency of cd34+ hematopoietic stem cells using poloxamers or lentiblast premium®: optimization toward a gene therapy procedure for sickle cell disease
